Your browser doesn't support javascript.
loading
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Carinato, Hélène; Burgy, Mickaël; Ferry, Régine; Fischbach, Cathie; Kalish, Michal; Guihard, Sébastien; Brahimi, Youssef; Flesch, Henri; Bronner, Guy; Schultz, Philippe; Frasie, Véronique; Thiéry, Alicia; Demarchi, Martin; Petit, Thierry; Jung, Alain C; Wagner, Pierre; Coliat, Pierre; Borel, Christian.
Affiliation
  • Carinato H; Institut de Cancérologie Strasbourg Europe, Department of Medical Oncology, Strasbourg, France.
  • Burgy M; Institut de Cancérologie Strasbourg Europe, Department of Medical Oncology, Strasbourg, France.
  • Ferry R; Centre Paul Strauss, Department of Medical Oncology, Strasbourg, France.
  • Fischbach C; Institut de Cancérologie Strasbourg Europe, Department of Medical Oncology, Strasbourg, France.
  • Kalish M; Institut de Cancérologie Strasbourg Europe, Department of Medical Oncology, Strasbourg, France.
  • Guihard S; Institut de Cancérologie Strasbourg Europe, Department of Radiation Oncology, Strasbourg, France.
  • Brahimi Y; Institut de Cancérologie Strasbourg Europe, Department of Radiation Oncology, Strasbourg, France.
  • Flesch H; Clinique Sainte Barbe, Head and Neck Surgery Unit, Strasbourg, France.
  • Bronner G; Clinique Sainte Barbe, Head and Neck Surgery Unit, Strasbourg, France.
  • Schultz P; Hôpitaux Universitaires de Strasbourg, Department of Otorhinolaryngology and Head and Neck Surgery, Strasbourg, France.
  • Frasie V; Institut de Cancérologie Strasbourg Europe, Supportive Care Unit, Strasbourg, France.
  • Thiéry A; Institut de Cancérologie Strasbourg Europe, Department of Biostatistics, Strasbourg, France.
  • Demarchi M; Institut de Cancérologie Strasbourg Europe, Department of Medical Oncology, Strasbourg, France.
  • Petit T; Institut de Cancérologie Strasbourg Europe, Department of Medical Oncology, Strasbourg, France.
  • Jung AC; Institut de Cancérologie Strasbourg Europe, Laboratoire de Biologie Tumorale, Strasbourg, France.
  • Wagner P; Université de Strasbourg, Inserm, UMR_S1113, Strasbourg, France.
  • Coliat P; Centre Paul Strauss, Department of Radiology, Strasbourg, France.
  • Borel C; Institut de Cancérologie Strasbourg Europe, Pharmacy Department, Strasbourg, France.
Front Oncol ; 11: 714551, 2021.
Article de En | MEDLINE | ID: mdl-34778031
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Front Oncol Année: 2021 Type de document: Article Pays d'affiliation: France Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Front Oncol Année: 2021 Type de document: Article Pays d'affiliation: France Pays de publication: Suisse